Match!

Type 2 diabetes: the epidemic of the new millennium.

Published on Jan 1, 1999in Annals of Clinical and Laboratory Science0.96
L Jovanovic1
Estimated H-index: 1
,
B Gondos1
Estimated H-index: 1
Abstract
The increasing prevalence of obesity, which has reached epidemic proportions, raises the likelihood that a similar increase in diabetes will follow. Linkage between the two conditions is clear. Overweight is not only an important risk factor for the development of diabetes, but also has a significant impact on progression and complications. Diagnostic criteria for the recognition of diabetes and for monitoring of the disease process will become increasingly important. The role of laboratory evaluation needs to be reassessed in light of new concepts regarding classification and diagnostic criteria. The relative utility of glucose and glycosylated protein measurements should be addressed, particularly the relationship between laboratory findings and clinical guidelines. Blood glucose monitoring depends on establishment of the threshold for diagnosis. Additional issues are bedside monitoring, the goal of noninvasive glucose sensors and targeting of therapy. The laboratory scientist is likely to play a key role in the application of advances in the detection and management of diabetes.
  • References (0)
  • Citations (24)
📖 Papers frequently viewed together
199815.27Diabetes Care
3 Authors (Hilary King, ..., William H. Herman)
4,921 Citations
199915.27Diabetes Care
17 Authors (James R. Gavin, ..., Michael P. Stern)
9,139 Citations
2 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References0
Newest
Cited By24
Newest
#1Barbara A. Stetson (University of Louisville)H-Index: 12
#2Stephanie McDonough (University of Louisville)
Last. Sri Prakash Mokshagundam (University of Louisville)H-Index: 9
view all 3 authors...
Diabetes mellitus has reached unprecedented proportions worldwide. The WHO estimated that in 2012 there were 347 million individuals with diabetes mellitus worldwide affecting ~9 % of the population >18 years of age. It is projected that between 2005 and 2030 deaths due to diabetes would have doubled. Due to the rapid increase in obesity prevalence globally, the World Health Organization (WHO) has declared that there is now a global epidemic of obesity. Internationally, emergence of new cases of...
Source
#1Chandrika N. Wijeyaratne (UoC: University of Colombo)H-Index: 16
#2Adam H. BalenH-Index: 48
Last. Paul E. BelchetzH-Index: 7
view all 3 authors...
The syndrome has vast epidemiological, socio-economic and health care delivery implications for south Asia DOI: http://dx.doi.org/10.4038/cmj.v47i1.6404 Ceylon Medical Journal 2002; 47(1): 22-26
10 CitationsSource
#1Sónia Norberto (University of Porto)H-Index: 10
#2Sara SilvaH-Index: 12
Last. Conceição Calhau (University of Porto)H-Index: 31
view all 6 authors...
Abstract Diet has gained scientific community attention due to the crucial role in health maintenance, but also in disease treatment, and essential in disease prevention. Several food and food components, particularly phenolic rich foods, have been investigated as they present themselves as putative functional foods. In the past decades, obesity has reached epidemic proportions and consequently, metabolic syndrome (a set of disorders as impaired glucose tolerance, insulin resistance, abdominal o...
84 CitationsSource
Background and purpose Exendin-4 (EX4) has the same physiological properties as glucagon-like peptide-1 (7-36)amide (GLP-1). EX4 has 50% identity with GLP-1, with an extra nine amino acids at its C-terminus. The two peptides mediate their functions through coupling to the glucagon like peptide-1 receptor (GLP-1R) with similar affinity and potency. Unlike N-terminally truncated GLP-1, (GLP-1(15-36)amide), the equivalently truncated EX4(9-39) binds GLP-1R without significant loss of affinity; furt...
#1Barbara A. StetsonH-Index: 12
#2Sri Prakash Mokshagundam (University of Louisville)H-Index: 9
Source
#1Paul S. Humphries (Pfizer)H-Index: 10
#2John William Benbow (Pfizer)H-Index: 8
Last. Xiaojing Yang (Pfizer)H-Index: 1
view all 15 authors...
The development of a series of novel 1,2,3,4-tetrahydroisoquinolin-1-ones as antagonists of G protein-coupled receptor 40 (GPR40) is described. The synthesis, in vitro inhibitory values for GPR40, in vitro microsomal clearance and rat in vivo clearance data are discussed. Initial hits displayed high rat in vivo clearances that were higher than liver blood flow. Optimization of rat in vivo clearance was achieved and led to the identification of 15i, whose rat oral pharmacokinetic data is reported...
45 CitationsSource
#1Claudia Chaufan (UCSF: University of California, San Francisco)H-Index: 8
#2Rose Weitz (ASU: Arizona State University)H-Index: 17
Over two hundred years of anecdotal, epidemiological, and experimental evidence indicate that poverty breeds disease. This holds true for type 2 diabetes, which both in the United States and other developed nations disproportionately occurs, cripples, and kills among the poor. In this article we examine rhetorical strategies used in 30 journal articles indexed under type 2 diabetes and poverty. As we show, poverty is rarely highlighted in this literature as a causal factor. Instead, explanations...
17 CitationsSource
#1Barbara A. Stetson (University of Louisville)H-Index: 12
#2Sri Prakash Mokshagundam (University of Louisville)H-Index: 9
In the USA, 44% of persons with self-reported diagnosed diabetes are aged 65 years or older and 18% are over age 75 years. The aim of diabetes intervention is to prevent or delay the development of long-term complications of high blood glucose and related metabolic abnormalities and improve the quality of life. “Metabolic syndrome” refers to a cluster of abnormalities that includes hypertension, dyslipidemia, abnormal blood glucose, and abdominal obesity. Over 40% of adults over the age of 70 ha...
2 CitationsSource
#1Uc San FranciscoH-Index: 1
In this paper I analyze the concept of heritability as used technically in medical research. I use diabetes as a paradigmatic “common disease” whose heritability is computed with a view to disentangling the relative contributions of “nature” and “nurture”. I show what heritability measures and what it does not, and theorize about the scope of application of this measurement for diabetes-relevant medical research, health care practices, and public health policies. I argue that this analysis appli...
1 Citations